- Home
- BBDO vs IQV Comparison
BBDO vs IQV Comparison
Compare BBDO & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBDO
- IQV
- Stock Information
- Founded
- BBDO 1943
- IQV 1982
- Country
- BBDO Brazil
- IQV United States
- Employees
- BBDO N/A
- IQV N/A
- Industry
- BBDO Major Banks
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BBDO Finance
- IQV Health Care
- Exchange
- BBDO Nasdaq
- IQV Nasdaq
- Market Cap
- BBDO 28.5B
- IQV 31.0B
- IPO Year
- BBDO N/A
- IQV 2013
- Fundamental
- Price
- BBDO $2.76
- IQV $187.17
- Analyst Decision
- BBDO Strong Buy
- IQV Strong Buy
- Analyst Count
- BBDO 4
- IQV 20
- Target Price
- BBDO $2.55
- IQV $229.15
- AVG Volume (30 Days)
- BBDO 29.5K
- IQV 1.2M
- Earning Date
- BBDO 10-30-2025
- IQV 10-30-2025
- Dividend Yield
- BBDO 4.21%
- IQV N/A
- EPS Growth
- BBDO 58.81
- IQV N/A
- EPS
- BBDO 0.36
- IQV 6.92
- Revenue
- BBDO $16,114,445,927.00
- IQV $15,700,000,000.00
- Revenue This Year
- BBDO $72.65
- IQV $6.01
- Revenue Next Year
- BBDO $8.90
- IQV $5.05
- P/E Ratio
- BBDO $8.13
- IQV $27.04
- Revenue Growth
- BBDO 27.09
- IQV 3.60
- 52 Week Low
- BBDO $1.71
- IQV $134.65
- 52 Week High
- BBDO $2.88
- IQV $248.03
- Technical
- Relative Strength Index (RSI)
- BBDO 60.81
- IQV 51.60
- Support Level
- BBDO $2.69
- IQV $183.10
- Resistance Level
- BBDO $2.80
- IQV $191.86
- Average True Range (ATR)
- BBDO 0.07
- IQV 4.72
- MACD
- BBDO 0.01
- IQV -0.57
- Stochastic Oscillator
- BBDO 75.62
- IQV 65.32
About BBDO Banco Bradesco Sa (each representing one Common Share)
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.